Simamis

Leaflet attached to the packaging: information for the user

Symamis, 50 mg, tablets

Symamis, 100 mg, tablets

Symamis, 200 mg, tablets

Symamis, 400 mg, tablets

Amisulpride

Read the leaflet carefully before taking the medicine, as it contains important information for the patient.

• Keep this leaflet, so you can read it again if you need to.
• If you have any doubts, consult a doctor or pharmacist.
• This medicine has been prescribed specifically for you. Do not pass it on to others. The medicine may harm another person, even if their symptoms are the same.
• If the patient experiences any side effects, including any side effects not listed in this leaflet, they should tell their doctor or pharmacist. See section 4.

Table of contents of the leaflet

• 1. What is Symamis and what is it used for
• 2. Important information before taking Symamis
• 3. How to take Symamis
• 4. Possible side effects
• 5. How to store Symamis
• 6. Contents of the packaging and other information

1. What is Symamis and what is it used for

Symamis is a medicine used to treat mental disorders (antipsychotic).
It reduces the activity of certain areas of the brain that are relevant to the symptoms of mental illnesses.
Symamis is used to treat a disease called schizophrenia. Schizophrenia is a long-term mental state that affects the patient's thinking, perception, and behavior compared to normal.
The doctor may also prescribe Symamis to treat other symptoms. You should always follow the doctor's instructions.

2. Important information before taking Symamis

The doctor may also prescribe Symamis to treat symptoms other than those listed in this leaflet. You should always follow the doctor's instructions and the dosage instructions described in this leaflet.

When not to take Symamis:

• if the patient is allergic to amisulpride or any of the other ingredients of this medicine (listed in section 6);
• if the patient has breast cancer;
• if the patient has a pituitary tumor;
• if the patient has an adrenal gland tumor (pheochromocytoma);
• during breastfeeding;
• if the patient has a rare inherited heart disease characterized by a slow heart rate and irregular heartbeat (long QT syndrome);

1

• if the patient is taking medicines that affect heart function (QT interval prolongation), such as:
• medicines used to treat Parkinson's disease (levodopa);
• medicines used to treat heart rhythm disorders (e.g., amiodarone, sotalol).

Symamis should not be used in children before puberty.

Warnings and precautions

Before starting Symamis, the patient should discuss with their doctor or pharmacist if:

• the patient has heart disease or has had heart disease in their family;
• there is a history of rare inherited heart disease with a slow heart rate and irregular heartbeat (long QT syndrome) in the patient's family;
• the patient has kidney problems;
• the patient has epilepsy or has had seizures in the past;
• the patient has Parkinson's disease;
• the patient has diabetes or is at risk of developing diabetes;
• the patient or their family members have had blood clots (thrombosis), as taking medicines like Symamis may increase the risk of blood clots;
• the patient or their family members have had breast cancer.

The patient should immediately inform their doctor if:

• the patient experiences general malaise, has a tendency to infections, especially sore throat and fever (infections) due to a low white blood cell count (agranulocytosis);
• the patient experiences fever, muscle stiffness, altered consciousness, and excessive sweating. This condition can lead to death and requires immediate medical attention.

Note: in certain patient groups (elderly patients and patients with dementia), there is an increased risk of side effects, including stroke. The patient should consult their doctor.
The patient should inform their doctor if they are undergoing blood or urine tests while taking Symamis, as this medicine may affect the results of these tests.

Symamis and other medicines

The patient should tell their doctor or pharmacist about all medicines they are currently taking or have recently taken, as well as any medicines they plan to take. Amisulpride may affect the action of other medicines. Additionally, other medicines may affect the action of amisulpride.

Do not take Symamis with medicines that may affect heart function (QT interval prolongation):

• medicines used to treat heart rhythm disorders (e.g., quinidine, disopyramide, amiodarone, and sotalol);
• certain antibiotics (e.g., intravenous erythromycin);
• medicines used to treat Parkinson's disease (e.g., levodopa, bromocriptine, ropinirole).

The patient should inform their doctor if they are taking any of the following medicines:

• medicines used to treat high blood pressure (diltiazem, verapamil, beta-blockers, e.g., metoprolol);
• medicines used to treat heart rhythm disorders (digoxin);
• medicines used to treat migraine and facial flushing (clonidine);
• certain groups of diuretics;
• medicines used to treat constipation (sodium picosulfate, bisacodyl);
• medicines used to treat arthritis or connective tissue disorders (corticosteroids, e.g., prednisone);
• medicines used to treat anxiety and restlessness (benzodiazepines);

2

• antidepressants (imipramine);
• other medicines used to treat mental illnesses (e.g., pimozide, haloperidol, lithium, clozapine);
• medicines used to treat epilepsy (phenobarbital);
• painkillers (e.g., morphine, oxycodone, tramadol);
• antihistamines that cause drowsiness (sedating antihistamines);
• sedatives;
• anesthetics used during surgery;
• anti-cough medications.

The patient should inform their doctorabout taking Symamis if they are going to have their adrenaline levels tested.

Symamis and alcohol

The patient should not drink alcohol while taking Symamis, as it may enhance the sedative effect of the medicine.

Pregnancy and breastfeeding

If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a child, they should consult their doctor before taking this medicine.

The following symptoms may occur in newborns whose mothers took amisulpride in the last trimester of pregnancy (last three months of pregnancy):

• tremors, muscle stiffness, and (or) weakness,
• drowsiness, agitation, breathing difficulties,
• feeding difficulties. If such symptoms are observed in the child, the patient should contact their doctor.

The patient should not take Symamis while breastfeeding.

Driving and operating machinery

While taking this medicine, the patient may experience reduced alertness and blurred vision. If such symptoms occur, the patient should not drive or operate tools or machinery.

Symamis contains lactose

Symamis contains lactose, a type of sugar. If the patient has previously been diagnosed with intolerance to some sugars, they should contact their doctor before taking the medicine.

Symamis contains sodium

This medicinal product contains less than 1 mmol of sodium (23 mg) per tablet, which means the product is considered "sodium-free".

3. How to take Symamis

This medicine should always be taken as directed by the doctor. If the patient has any doubts, they should consult their doctor or pharmacist.
The recommended dose is:

Adults

The doctor will adjust the dose according to the patient's response to treatment. The usual dose of Symamis is 50-300 mg per day or 400-800 mg per day, depending on the symptoms of the disease.
In individual cases, the dose may be increased to 1200 mg per day.
If the patient takes a single dose greater than 400 mg per day, the dose should be divided into two doses.
Use in children and adolescents
Symamis should not be given to children before puberty.

Use in patients with kidney problems

If the patient has reduced kidney function, the doctor may recommend a lower dose. The patient should follow the doctor's instructions.

Instructions for taking the medicine

The patient should swallow the Symamis tablet before a meal, with a large amount of water.
Symamis, 200 mg, and Symamis, 400 mg: the dividing line on the tablet is only to facilitate breaking the tablet, not to divide it into equal doses.

Taking a higher dose of Symamis than recommended

If the patient takes a higher dose of Symamis than recommended, they should immediately contact their doctor or go to the nearest hospital. The patient should take the medicine packaging with them.
Overdose symptoms may include: drowsiness, sedation, involuntary movements, dizziness, fainting (due to low blood pressure), and coma.

Missing a dose of Symamis

The patient should not take a double dose to make up for a missed dose. The patient should continue treatment with the usual dose.

Stopping Symamis treatment

Treatment can only be stopped or discontinued after consulting a doctor.
If the patient has any further doubts about taking this medicine, they should consult their doctor or pharmacist.

4. Possible side effects

Like all medicines, Symamis can cause side effects, although not everybody gets them.

Serious side effects

Common:may affect up to 1 in 10 patients

• altered consciousness related to excessive drowsiness. The patient should contact their doctor;
• eye muscle spasms with forced upward gaze. The patient should contact their doctor;
• rapid or very irregular heartbeat, which can lead to a heart attack. The patient should immediately contact their doctor or go to the nearest emergency department.

Uncommon:may affect up to 1 in 100 patients

• seizures. The patient should immediately contact their doctor or go to the nearest emergency department;
• slow heart rate. The patient should contact their doctor or go to the nearest emergency department;
• general malaise, tendency to infections (infections), especially sore throat and fever, due to changes in blood (decreased white blood cell count, agranulocytosis). The patient should contact their doctor or go to the nearest emergency department.

Rare:may affect up to 1 in 1000 patients

• high fever, muscle stiffness, excessive sweating, confusion, drowsiness, or agitation (neuroleptic malignant syndrome). If the patient notices these symptoms, they should immediately seek medical attention;
• blood clots in the veins, especially in the legs (symptoms include swelling, pain, and redness of the leg). Blood clots can move through the bloodstream to the lungs, causing chest pain and breathing difficulties. If any of these symptoms occur, the patient should immediately seek medical attention;
• pituitary tumor (manifested by milk secretion from the breasts and menstrual disorders) caused by increased levels of hormone (prolactin) in the blood. In men: breast enlargement and erectile dysfunction.

Unknown: frequency cannot be estimated from the available data

• withdrawal syndrome in newborns (see section "Pregnancy and breastfeeding").

Other side effects

Very common:may affect more than 1 in 10 patients

• slow, involuntary, twisting movements;
• side effects similar to Parkinson's disease symptoms: slow, involuntary tremors of hands and head, stiffness of movements, stiffness of facial expressions, muscle tension, and increased salivation;
• twisting movements, especially of the lower limbs.

Common:may affect up to 1 in 10 patients

• neck twisting due to muscle spasms;
• reduced ability to open the jaw due to increased muscle tension;
• constipation, nausea, vomiting, dry mouth, which can increase the risk of tooth decay;
• dizziness, possible fainting due to low blood pressure;
• breast enlargement in men, chest tightness, milk secretion, menstrual disorders;
• erectile dysfunction, inability to achieve orgasm;
• insomnia, anxiety, agitation;
• weight gain;
• blurred vision.

Uncommon:may affect up to 1 in 100 patients

• slow, involuntary movements. These may disappear after stopping the medicine;
• frequent urination, thirst, fatigue due to high blood sugar (glucose) levels; may develop into serious side effects. The patient should contact their doctor;
• allergic reactions;
• increased risk of atherosclerosis due to high cholesterol and/or fat (triglyceride) levels in the blood;
• confusion;
• high blood pressure;
• nasal congestion (stuffy nose);
• pneumonia;
• increased risk of fractures due to osteopenia and osteoporosis. May develop into serious side effects. The patient should contact their doctor if they experience sudden back pain.

Rare:may affect up to 1 in 1000 patients

• rash and swelling. May be severe. The patient should contact their doctor. Facial, lip, and tongue swelling can be life-threatening. If the patient notices such symptoms, they should immediately seek medical attention;
• nausea, discomfort, muscle weakness, and confusion due to low sodium levels in the blood (hyponatremia). May be (or develop into) a serious side effect. The patient should contact their doctor;
• syndrome of inappropriate antidiuretic hormone secretion (SIADH).

Amisulpride may cause side effects that the patient does not notice. These are usually changes visible in laboratory test results due to changes in blood, liver, or heart rhythm. Laboratory test results will return to normal after stopping treatment.

Reporting side effects

If the patient experiences any side effects, including any side effects not listed in this leaflet, they should tell their doctor or pharmacist. Side effects can be reported directly to the Department of Drug Safety Monitoring of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products:
Aleje Jerozolimskie 181C, 02-222 Warsaw, Tel.: +48 22 49 21 301, Fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl .
Side effects can also be reported to the marketing authorization holder.
Reporting side effects will help gather more information on the safety of the medicine.

5. How to store Symamis

The medicine should be stored out of sight and reach of children.
The patient should not use the medicine after the expiration date stated on the carton or blister pack after EXP. The expiration date refers to the last day of the specified month.
There are no special precautions for storing the medicine.
Medicines should not be disposed of via wastewater or household waste. The patient should ask their pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.

6. Contents of the packaging and other information

What Symamis contains

The active substance of the medicine is amisulpride. Each tablet contains 50 mg, 100 mg, 200 mg, or 400 mg of amisulpride.
The other ingredients are: lactose monohydrate, sodium carboxymethylcellulose (type A), hypromellose 2910, microcrystalline cellulose PH-101, magnesium stearate.

What Symamis looks like and what the pack contains

Symamis, 50 mg: white, round, flat tablets with a diameter of 7 mm.
Symamis, 100 mg: white, round, flat tablets with a diameter of 9.5 mm, with the inscription MC on one side.
Symamis, 200 mg: white, round, flat tablets with a diameter of 11.5 mm, with a dividing line on one side. The dividing line on the tablet is only to facilitate breaking the tablet, not to divide it into equal doses.
Symamis, 400 mg: white, biconvex tablets in the shape of a capsule, with a dividing line on both sides, measuring 19 mm x 10 mm. The dividing line on the tablet is only to facilitate breaking the tablet, not to divide it into equal doses.
PVC/PE/PVDC-Aluminum or PVC/PVDC-Aluminum blisters, containing 30, 60, or 90 tablets, in a cardboard box.
Not all pack sizes may be marketed.

Marketing authorization holder and manufacturer

Marketing authorization holder

Symphar Sp. z o.o.
Koszykowa 65
00-667 Warsaw

Manufacturer

Medochemie Ltd
1-10 Constantinoupoleos Street, 3011, Limassol
Cyprus
Date of last update of the leaflet:November 2020
7